NORDEN GROUP LLC

Position in ZTS — Zoetis Inc.

CIK 1990699 PROVO, UT

Position in ZTS

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$249,929

-$1,784,819 QoQ

Shares Held

3,478

-79.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#985

of 1,408 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORDEN GROUP LLC holds $1,174,124 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (21.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	608	$329,432
2	LNTH	Lantheus Holdings, Inc.	2,626	$291,328
3	ZTS	Zoetis Inc. This page	3,478	$249,929
4	NBIX	Neurocrine Biosciences Inc	1,457	$245,562
5	AQST	Aquestive Therapeutics, Inc.	13,912	$57,873

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$249,929	3,478	-79.8%	Shares	Sole	2026-07-29
2026-03-31	$2,034,748	17,213	+22.4%	Shares	Sole	2026-04-15
2025-12-31	$1,769,784	14,066	-26.6%	Shares	Sole	2026-01-13
2025-09-30	$2,802,320	19,152	-16.8%	Shares	Sole	2025-10-15
2025-06-30	$3,591,060	23,027	-1.3%	Shares	Sole	2025-07-15
2025-03-31	$3,841,943	23,334	-0.1%	Shares	Sole	2025-05-07
2024-12-31	$3,804,089	23,348	+18.1%	Shares	Sole	2025-02-05
2024-09-30	$3,861,881	19,766	+110.7%	Shares	Sole	2024-10-17
2024-06-30	$1,626,636	9,383	-20.8%	Shares	Sole	2024-08-06
2024-03-31	$2,004,291	11,845	+83.1%	Shares	Sole	2024-04-30
2023-12-31	$1,276,786	6,469	-10.9%	Shares	Sole	2024-02-05
2023-09-30	$1,263,268	7,261	—	Shares	Sole	2023-11-06
No filing history on record for this holder in this stock.